Exelixis
EXEL
#1637
Rank
C$14.70 B
Marketcap
$52.53
Share price
-0.38%
Change (1 day)
62.05%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $70.49 CAD on 2000-07-26

Lowest end of day price: $1.85 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$55.45 0.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
$79.90 1.66%๐Ÿ‡ซ๐Ÿ‡ท France
$127.72 1.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$85.91 1.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$439.36 0.39%๐Ÿ‡บ๐Ÿ‡ธ USA
$234.33 0.36%๐Ÿ‡บ๐Ÿ‡ธ USA
$36.08 0.80%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.32-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.47 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA